financetom
Business
financetom
/
Business
/
KKR Pick of the Week at Smart Insider Following Non-Executive Robert Scully Stock Purchase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
KKR Pick of the Week at Smart Insider Following Non-Executive Robert Scully Stock Purchase
May 26, 2025 6:44 AM

09:13 AM EDT, 05/13/2025 (MT Newswires) -- KKR (KKR) was Smart Insider's stock pick of the week after the company's non-executive Robert Scully bought $1.5 million worth of KKR's shares on May 6 at $113.49 apiece, raising his ownership by 8%.

Scully has an "excellent" record as a buyer at the company and in his other non-executive roles at Chubb (CB) and Zoetis (ZTS), qualifying as a "Smart Buyer," Smart Insider said in a Tuesday note.

The note also added that Scully previously bought shares on four different occasions, and it ranked the stock on the last three of these purchases, which provided "strong returns."

"It's encouraging to see him now buying at more than 2x the price of his previous purchase," according to the note.

Smart Insider ranked the stock +1, or strongly positive signal, on Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kingsway Pharmaceuticals Acquires Strategic Equity Stake in CIGA Healthcare to Expand Access to At-Home and Retail Diagnostic Testing
Kingsway Pharmaceuticals Acquires Strategic Equity Stake in CIGA Healthcare to Expand Access to At-Home and Retail Diagnostic Testing
Nov 17, 2025
BRISTOL, Tenn., Nov. 17, 2025 /PRNewswire/ -- Kingsway Pharmaceuticals, a U.S.-based consumer healthcare company specializing in nationally distributed OTC brands and private label solutions, announced today that it has acquired a strategic minority stake in CIGA Healthcare, a global diagnostics innovator supplying rapid tests and home diagnostic technologies to more than 70 countries. The investment forms a joint venture alignment...
Form 8.3
Form 8.3
Nov 17, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: BALYASNY ASSET MANAGEMENT L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Form 8.3
Form 8.3
Nov 17, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: BALYASNY ASSET MANAGEMENT L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Merlin Labs, Inc. and Inflection Point Acquisition Corp. IV Announce Upsizing of PIPE Investment to More Than $200 Million
Merlin Labs, Inc. and Inflection Point Acquisition Corp. IV Announce Upsizing of PIPE Investment to More Than $200 Million
Nov 17, 2025
Inflection Point and investors increase PIPE commitments to more than $200 million, including over $85 million of pre-funded PIPE capital BOSTON--(BUSINESS WIRE)-- Merlin Labs, Inc. (“Merlin”), a leading developer of assured, autonomous flight technology for defense customers, and Inflection Point Acquisition Corp. IV ( BACQ ) (“Inflection Point”) today announced a significant increase to their previously disclosed private investment...
Copyright 2023-2026 - www.financetom.com All Rights Reserved